New eye drops aim to ease dry eye symptoms for millions
NCT ID NCT07457021
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will test perfluorohexyloctane eye drops, the only approved drug in China for dry eye disease related to meibomian gland dysfunction. Researchers plan to enroll 2000 adults and track their symptoms, eye health, and any side effects over 12 weeks. The goal is to see how well the drops work in real-world conditions, alone or with other treatments.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
perfluorohexyloctane eye drops
What this could lead to
If successful, this could confirm that perfluorohexyloctane eye drops are a safe and effective option for treating dry eye symptoms in everyday medical practice.
What could go wrong
This is an observational real-world study, not a controlled trial, so results may be less definitive. Side effects or lack of benefit are possible, and the study has not yet started recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Xiamen Eye Center Affiliated to Xiamen University
Xiamen, China
Contact Phone: •••-•••-•••• Email: •••••@•••••